NIH/CDC/FDA Parent SBIR Grant [R43/R44] (Clinical Trial Optional)
The NIH, CDC, and FDA utilize the Omnibus solicitation for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. These parent announcements support the development of innovative technologies and products for commercialization, covering a vast range of biomedical and clinical research areas through the R43/R44 funding mechanisms.
Deadline
Rolling
Est. Time
3-6 months for proposal development
Source
SBIR/STTR
Eligibility Requirements
Small business concerns that are organized for-profit, located in the U.S., and meet specific size standards (500 or fewer employees). Principal investigators must have their primary employment with the small business at the time of award.
Who Can Apply
U.S.-based for-profit small business concerns.
Application Instructions
Applications must be submitted electronically through Grants.gov. Applicants must register with SAM.gov, Grants.gov, and the eRA Commons prior to submission.
Required Documents
- SF424 (R&R) Application Package
- Research Strategy
- Budget Justification
- Specific Aims
- Biosketches
- Commercialization Plan
Geographic Restrictions
United States
Required Essays
- Research Strategy
- Commercialization Plan
- Specific Aims
How to Stand Out
Focus on the commercialization potential and the innovation of the technology. Ensure the specific aims are highly focused and that the team has the necessary expertise to execute the proposed work.
Risk Warnings
The application process is highly competitive and requires strict adherence to NIH formatting guidelines and deadlines. Late applications are generally not accepted.